Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 121 AL 135

Automated tractography of the cingulate bundle in Alzheimer's disease: a multicenter DTI study

Fischer FU, Scheurich A, Wegrzyn M, Schermuly I, Bokde AL, Klöppel S, Pouwels PJ, Teipel S, Yakushev I, Fellgiebel A.

J Magn Reson Imaging. 2012 Jul;36(1):84-91. doi: 10.1002/jmri.23621. Epub 2012 Feb 22.

Protein homeostasis, aging and Alzheimer's disease

Morawe T, Hiebel C, Kern A, Behl C.

Mol Neurobiol. 2012 Aug;46(1):41-54. doi: 10.1007/s12035-012-8246-0. Epub 2012 Feb 24.

Epigenetics: a paradigm shift in understanding Alzheimer's disease

Zawia NH, Lahiri DK.

Curr Alzheimer Res. 2012 Jun;9(5):525-6. doi: 10.2174/156720512800617973.

Metal-associated amyloid-β species in Alzheimer's disease

Pithadia AS, Lim MH.

Curr Opin Chem Biol. 2012 Apr;16(1-2):67-73. doi: 10.1016/j.cbpa.2012.01.016. Epub 2012 Feb 25.

A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer's disease

Harrison FE.

J Alzheimers Dis. 2012;29(4):711-26. doi: 10.3233/JAD-2012-111853.

Regulation of cerebral cholesterol metabolism in Alzheimer disease

Reiss AB, Voloshyna I.

J Investig Med. 2012 Mar;60(3):576-82. doi: 10.2310/JIM.0b013e318246d973.

Roles of AMP-activated protein kinase in Alzheimer's disease

Cai Z, Yan LJ, Li K, Quazi SH, Zhao B.

Neuromolecular Med. 2012 Mar;14(1):1-14. doi: 10.1007/s12017-012-8173-2. Epub 2012 Feb 26.

Role of ligand-based drug design methodologies toward the discovery of new anti- Alzheimer agents: futures perspectives in Fragment-Based Ligand Design

Speck-Planche A, Luan F, Cordeiro MN.

Curr Med Chem. 2012;19(11):1635-45. doi: 10.2174/092986712799945058.

Inhibition of the NFAT pathway alleviates amyloid β neurotoxicity in a mouse model of Alzheimer's disease

Hudry E, Wu HY, Arbel-Ornath M, Hashimoto T, Matsouaka R, Fan Z, Spires-Jones TL, Betensky RA, Bacskai BJ, Hyman BT.

J Neurosci. 2012 Feb 29;32(9):3176-92. doi: 10.1523/JNEUROSCI.6439-11.2012.

The Telephone Interview for Cognitive Status (Modified): relation with a comprehensive neuropsychological assessment

van den Berg E, Ruis C, Biessels GJ, Kappelle LJ, van Zandvoort MJ.

J Clin Exp Neuropsychol. 2012;34(6):598-605. doi: 10.1080/13803395.2012.667066. Epub 2012 Mar 5.

Is seladin-1 really a selective Alzheimer's disease indicator?

Sharpe LJ, Wong J, Garner B, Halliday GM, Brown AJ.

J Alzheimers Dis. 2012;30(1):35-9. doi: 10.3233/JAD-2012-111955.

Effect of genetic variation in LRRTM3 on risk of Alzheimer disease

Reitz C, Conrad C, Roszkowski K, Rogers RS, Mayeux R.

Arch Neurol. 2012 Jul;69(7):894-900. doi: 10.1001/archneurol.2011.2463.

Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease

Holtzman DM, Herz J, Bu G.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a006312. doi: 10.1101/cshperspect.a006312.

Could antivirals be used to treat Alzheimer's disease?

Itzhaki RF, Wozniak MA.

Future Microbiol. 2012 Mar;7(3):307-9. doi: 10.2217/fmb.12.10.

Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease

Shahpasand K, Uemura I, Saito T, Asano T, Hata K, Shibata K, Toyoshima Y, Hasegawa M, Hisanaga S.

J Neurosci. 2012 Feb 15;32(7):2430-41. doi: 10.1523/JNEUROSCI.5927-11.2012.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias